What is Eye Surgeons Associates?
Founded in 1983, Eye Surgeons Associates operates as a premier provider of comprehensive ophthalmological and optical services. The organization distinguishes itself through a multidisciplinary approach, integrating general ophthalmology with specialized subspecialty care, hearing services, and advanced optical solutions. With a clinical team comprising nearly 20 practitioners, the practice addresses a broad spectrum of patient needs, ranging from routine vision correction and LASIK procedures to complex pediatric ophthalmology and diabetic eye health management. Their market position is defined by a commitment to high-tech diagnostic and surgical interventions, ensuring that patients receive personalized, evidence-based care that preserves and restores visual function.
How much funding has Eye Surgeons Associates raised?
Eye Surgeons Associates has raised a total of $2.8M across 2 funding rounds:
Debt
$1M
Debt
$1.8M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.8M led by PPP
Key Investors in Eye Surgeons Associates
PPP
Public-Private Partnership
What's next for Eye Surgeons Associates?
With the infusion of this recent capital, Eye Surgeons Associates is well-positioned to accelerate its strategic growth initiatives. The organization is expected to prioritize the modernization of its surgical infrastructure and the expansion of its diagnostic technology suite to maintain its competitive edge in the regional medical market. Furthermore, the firm will likely focus on scaling its patient-centric care models to accommodate increasing demand for specialized eye health services. By optimizing its operational efficiency and deepening its clinical expertise, Eye Surgeons Associates is poised to strengthen its role as a cornerstone of healthcare delivery in the Quad Cities, ensuring long-term sustainability and continued excellence in patient outcomes.
See full Eye Surgeons Associates company page
